XML 17 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating activities    
Net income $ 19,400 $ 16,169
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 241 222
Net amortization of investments 2,347 3,151
Deferred income taxes 5 264
Net realized (gains) losses on investments (59) 31
Net unrealized (gains) losses on equity securities (2,158) 390
Share-based compensation 565 18
Changes in operating assets and liabilities:    
Premiums receivable, net (11,832) (12,564)
Accrued interest receivable (720) (697)
Deferred policy acquisition costs (699) (1,036)
Amounts held by others   (7,855)
Other assets (998) 2,438
Reserves for loss and loss adjustment expenses 2,171 5,453
Unearned premiums 5,730 7,702
Reinsurance balances 824 (4,040)
Amounts held for others and policyholder deposits 871 402
Accounts payable and other liabilities 4,588 2,618
Net cash provided by operating activities 20,276 12,666
Investing activities    
Purchases of investments held-to-maturity (26,174) (17,925)
Purchases of investments available-for-sale (10,394) (28,510)
Purchases of equity securities (807)  
Purchases of short-term investments (64,320) (28,688)
Proceeds from maturities of investments held-to-maturity 40,578 19,127
Proceeds from sales and maturities of investments available-for-sale 26,365 25,004
Proceeds from sales and maturities of short-term investments 13,959 4,000
Purchases of property and equipment (22) (868)
Net cash used in investing activities (20,815) (27,860)
Financing activities    
Proceeds from stock option exercises 20 68
Finance lease purchases (12)  
Dividends to shareholders (4,918) (4,361)
Net cash used in financing activities (4,910) (4,293)
Change in cash and cash equivalents (5,449) (19,487)
Cash and cash equivalents at beginning of period 40,344 55,559
Cash and cash equivalents at end of period $ 34,895 $ 36,072